Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Synthetic Genomics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Synthetic Genomics Acquires DNA Technology Patent Portfolio From febit 10
Venture Financing 11
Synthetic Genomics Raises US$10 Million In Venture Financing 11
Partnerships 12
Janssen Vaccines & Prevention Enters into Research and Licensing Option Agreement with Synthetic Genomics 12
Synthetic Genomics Expands R&D Agreement with Lung Biotech 13
SGI-DNA Enters Into Agreement With Integrated DNA Technologies For Synthetic DNA Products 14
Licensing Agreements 15
Synthetic Genomics Enters into Licensing Agreement with Arcturus Therapeutics 15
Synthetic Genomics Enters Licensing Agreement with Gen9 for Synthetic Biology Technology Patents 16
New England Biolabs Enters Into Licensing Agreement With Synthetic Genomics 17
Equity Offering 18
Synthetic Genomics Raises USD50 Million in Private Placement of Shares 18
Synthetic Genomics Raises USD50 Million in Private Placement of Shares 19
Asset Transactions 20
C3J Therapeutics Acquires Bacteriophage Assets from Synthetic Genomics 20
Acquisition 21
Monsanto Invests In Synthetic Genomics, Developer Of Genomic-Driven Solutions 21
Synthetic Genomics Inc – Key Competitors 22
Synthetic Genomics Inc – Key Employees 23
Synthetic Genomics Inc – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Corporate Communications 25
Aug 14, 2018: Synthetic Genomics announces changes to its Board of Directors 25
Jun 25, 2018: Synthetic Genomics Names Reinhard J. Ambros As Board Director 26
Government and Public Interest 27
Oct 26, 2017: Synthetic Genomics Partners with Duke Human Vaccine Institute on DARPA Pandemic Prevention Platform Program 27
Product News 28
Aug 22, 2017: BioXp Genomic Workstation Makes European Debut at VIB Research Institute in Belgium 28
Jun 01, 2017: Synthetic Genomics Launches cGMP Suite for Pharmaceutical Quality Manufacturing of Synthetic DNA for Advaxis’ Clinical Trials 29
Jan 09, 2017: Synthetic Genomics Launches Vmax Express, a Next-Generation Protein Expression Platform for the Biotech Industry 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Synthetic Genomics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Synthetic Genomics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Synthetic Genomics Acquires DNA Technology Patent Portfolio From febit 10
Synthetic Genomics Raises US$10 Million In Venture Financing 11
Janssen Vaccines & Prevention Enters into Research and Licensing Option Agreement with Synthetic Genomics 12
Synthetic Genomics Expands R&D Agreement with Lung Biotech 13
SGI-DNA Enters Into Agreement With Integrated DNA Technologies For Synthetic DNA Products 14
Synthetic Genomics Enters into Licensing Agreement with Arcturus Therapeutics 15
Synthetic Genomics Enters Licensing Agreement with Gen9 for Synthetic Biology Technology Patents 16
New England Biolabs Enters Into Licensing Agreement With Synthetic Genomics 17
Synthetic Genomics Raises USD50 Million in Private Placement of Shares 18
Synthetic Genomics Raises USD50 Million in Private Placement of Shares 19
C3J Therapeutics Acquires Bacteriophage Assets from Synthetic Genomics 20
Monsanto Invests In Synthetic Genomics, Developer Of Genomic-Driven Solutions 21
Synthetic Genomics Inc, Key Competitors 22
Synthetic Genomics Inc, Key Employees 23
Synthetic Genomics Inc, Subsidiaries 24
List of Figures
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8